A batch document is useful only when it matches the product in front of you. A pharmaceutical certificate of analysis, or CoA, records analytical information for an identified sample or batch. Buyers should understand its role, recognise the key identifiers and send technical questions to the appropriate quality professionals.
What a pharmaceutical certificate of analysis tells you
The WHO publishes a model certificate of analysis as a reference for pharmaceutical quality-control documentation. For a buyer, the starting task is to connect the certificate to the ordered product and consignment, rather than treating a document with a familiar heading as sufficient evidence by itself.
Keep the distinction between a sample document supplied during discussions and the certificate relating to delivered stock. A sample can illustrate document format. It cannot establish the analytical results of a later commercial batch.
Match the identifiers first
Check the product description, strength, dosage form and batch or lot identifier against the relevant order and shipping records. Investigate discrepancies before filing the document as complete. If several batches arrive together, make sure the accompanying document set covers each one.
- Compare batch identifiers character by character.
- Check that the described presentation matches the order.
- Identify the issuing organisation and relevant document reference.
- Route date, expiry or retest discrepancies to the quality team.
Read results alongside specifications
A result without its acceptance criterion can be difficult to interpret. Ask your quality team to review the stated tests, specifications, units and results in the context of the agreed product specification. Purchasing staff should not independently approve unfamiliar analytical values or decide that an omitted test is unnecessary.
| Document area | Buyer's practical check |
|---|---|
| Identity | Does it match the ordered product and batch? |
| Specification reference | Can the quality team identify the applicable standard? |
| Results | Are units and reported outcomes understandable to reviewers? |
| Authorisation | Is the issue or approval information traceable? |
| Revision | Is a replacement clearly linked to the earlier document? |
Clarify the certificate's scope
Ask what the document represents and which records support it. A CoA is part of the quality documentation for a product; it is not a substitute for reviewing the manufacturing site, applicable authorisations or supplier quality arrangements. Nor should its presence be used to infer approval for every destination market.
Agree which documents will accompany shipments during the sourcing stage. This prevents the warehouse from discovering at receipt that a document needed by its quality team was never included in the commercial scope.
Handle queries through a traceable process
If an identifier is wrong or a result requires explanation, record the question with the batch number and document version. Ask for clarification from the authorised contact. Do not edit a supplier's certificate locally to make it match the consignment.
When a corrected certificate is issued, retain the relationship between versions and note why it changed. Ask the quality team whether the discrepancy affects stock status. The receiving team should follow its approved process while that decision is pending.
Build document review into receiving
Create a receiving checklist that connects the purchase order, physical labels, quantities, delivery paperwork and batch documentation. Decide who checks identifiers and who performs the technical review. A named owner makes an incomplete delivery easier to resolve.
Flemming Pharma's tablet and oral suspension categories can help you prepare a product enquiry. Ask the team which batch documents are available for your specific requirement, and review the wider sourcing checklist before placing an order.
